Connatal Pelizaeus-Merzbacher disease: a missense mutation in exon 4 of the proteolipid protein (PLP) gene

M Nagao1, J Kadowaki

  • 1Department of Pediatrics, National Otaru Hospital, Hokkaido, Japan. CXQ04341@niftyserve.or.jp

Journal of Human Genetics
|September 25, 1998
PubMed

Insights

Researchers identified a new mutation in the proteolipid protein (PLP) gene in two brothers with Pelizaeus-Merzbacher disease (PMD). This Asp202-to-Val substitution in the PLP gene may correlate with disease severity.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Pelizaeus-Merzbacher disease (PMD) is a rare, inherited neurological disorder.
  • The proteolipid protein (PLP) gene is crucial for myelin formation in the central nervous system.

Observation:

  • Two brothers in a Japanese family presented with a connatal form of Pelizaeus-Merzbacher disease.
  • Genetic analysis focused on the proteolipid protein (PLP) gene.

Findings:

  • Direct sequencing revealed a specific A-to-T transition in exon 4 of the PLP gene.
  • This mutation resulted in an Aspartic acid to Valine substitution at amino acid residue 202 (Asp202-to-Val).
  • The mutation was absent in 78 X-chromosomes from healthy Japanese individuals, indicating it is not a common polymorphism.

Implications:

  • The identified Asp202-to-Val mutation in the PLP gene is strongly associated with the observed connatal form of PMD.
  • A potential correlation between the specific PLP gene mutation and the clinical severity of PMD in the affected brothers is suggested.
  • This finding contributes to understanding the genetic basis of PMD and may aid in future diagnostics and genetic counseling.

Related Concept Videos

Mutations01:39

Mutations

Overview
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...